Global Personalized Cancer Medicine Supply, Demand and Key Producers, 2023-2029
The global Personalized Cancer Medicine market size is expected to reach $ 366720 million by 2029, rising at a market growth of 12.0% CAGR during the forecast period (2023-2029).
In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified on the basis of treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.
Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.
Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient's immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor's molecular characteristics.
Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient's cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.
This report studies the global Personalized Cancer Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Personalized Cancer Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Personalized Cancer Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Personalized Cancer Medicine total market, 2018-2029, (USD Million)
Global Personalized Cancer Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Personalized Cancer Medicine total market, key domestic companies and share, (USD Million)
Global Personalized Cancer Medicine revenue by player and market share 2018-2023, (USD Million)
Global Personalized Cancer Medicine total market by Method, CAGR, 2018-2029, (USD Million)
Global Personalized Cancer Medicine total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Personalized Cancer Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca and Merck & Co, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Personalized Cancer Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Method, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Personalized Cancer Medicine Market, By Region:
1. How big is the global Personalized Cancer Medicine market?
2. What is the demand of the global Personalized Cancer Medicine market?
3. What is the year over year growth of the global Personalized Cancer Medicine market?
4. What is the total value of the global Personalized Cancer Medicine market?
5. Who are the major players in the global Personalized Cancer Medicine market?
In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified on the basis of treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.
Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.
Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient's immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor's molecular characteristics.
Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient's cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.
This report studies the global Personalized Cancer Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Personalized Cancer Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Personalized Cancer Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Personalized Cancer Medicine total market, 2018-2029, (USD Million)
Global Personalized Cancer Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Personalized Cancer Medicine total market, key domestic companies and share, (USD Million)
Global Personalized Cancer Medicine revenue by player and market share 2018-2023, (USD Million)
Global Personalized Cancer Medicine total market by Method, CAGR, 2018-2029, (USD Million)
Global Personalized Cancer Medicine total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Personalized Cancer Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca and Merck & Co, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Personalized Cancer Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Method, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Personalized Cancer Medicine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cancer Immunotherapy
- Targeted Therapy
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Blood-related Cancer
- Other
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- GSK
- Exelixis
- Regeneron
- Innovent
- Hengrui Medicine
1. How big is the global Personalized Cancer Medicine market?
2. What is the demand of the global Personalized Cancer Medicine market?
3. What is the year over year growth of the global Personalized Cancer Medicine market?
4. What is the total value of the global Personalized Cancer Medicine market?
5. Who are the major players in the global Personalized Cancer Medicine market?
1 SUPPLY SUMMARY
1.1 Personalized Cancer Medicine Introduction
1.2 World Personalized Cancer Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Personalized Cancer Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Personalized Cancer Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Personalized Cancer Medicine Market Size (2018-2029)
1.3.3 China Personalized Cancer Medicine Market Size (2018-2029)
1.3.4 Europe Personalized Cancer Medicine Market Size (2018-2029)
1.3.5 Japan Personalized Cancer Medicine Market Size (2018-2029)
1.3.6 South Korea Personalized Cancer Medicine Market Size (2018-2029)
1.3.7 ASEAN Personalized Cancer Medicine Market Size (2018-2029)
1.3.8 India Personalized Cancer Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Personalized Cancer Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Personalized Cancer Medicine Major Market Trends
2 DEMAND SUMMARY
2.1 World Personalized Cancer Medicine Consumption Value (2018-2029)
2.2 World Personalized Cancer Medicine Consumption Value by Region
2.2.1 World Personalized Cancer Medicine Consumption Value by Region (2018-2023)
2.2.2 World Personalized Cancer Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Personalized Cancer Medicine Consumption Value (2018-2029)
2.4 China Personalized Cancer Medicine Consumption Value (2018-2029)
2.5 Europe Personalized Cancer Medicine Consumption Value (2018-2029)
2.6 Japan Personalized Cancer Medicine Consumption Value (2018-2029)
2.7 South Korea Personalized Cancer Medicine Consumption Value (2018-2029)
2.8 ASEAN Personalized Cancer Medicine Consumption Value (2018-2029)
2.9 India Personalized Cancer Medicine Consumption Value (2018-2029)
3 WORLD PERSONALIZED CANCER MEDICINE COMPANIES COMPETITIVE ANALYSIS
3.1 World Personalized Cancer Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Personalized Cancer Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Personalized Cancer Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Personalized Cancer Medicine in 2022
3.3 Personalized Cancer Medicine Company Evaluation Quadrant
3.4 Personalized Cancer Medicine Market: Overall Company Footprint Analysis
3.4.1 Personalized Cancer Medicine Market: Region Footprint
3.4.2 Personalized Cancer Medicine Market: Company Product Type Footprint
3.4.3 Personalized Cancer Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Personalized Cancer Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Personalized Cancer Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Personalized Cancer Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Personalized Cancer Medicine Consumption Value Comparison
4.2.1 United States VS China: Personalized Cancer Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Personalized Cancer Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Personalized Cancer Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Personalized Cancer Medicine Revenue, (2018-2023)
4.4 China Based Companies Personalized Cancer Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Personalized Cancer Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Personalized Cancer Medicine Revenue, (2018-2023)
4.5 Rest of World Based Personalized Cancer Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Personalized Cancer Medicine Revenue, (2018-2023)
5 MARKET ANALYSIS BY METHOD
5.1 World Personalized Cancer Medicine Market Size Overview by Method: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Method
5.2.1 Cancer Immunotherapy
5.2.2 Targeted Therapy
5.3 Market Segment by Method
5.3.1 World Personalized Cancer Medicine Market Size by Method (2018-2023)
5.3.2 World Personalized Cancer Medicine Market Size by Method (2024-2029)
5.3.3 World Personalized Cancer Medicine Market Size Market Share by Method (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Personalized Cancer Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Breast Cancer
6.2.3 Prostate Cancer
6.2.4 Blood-related Cancer
6.2.5 Blood-related Cancer
6.3 Market Segment by Application
6.3.1 World Personalized Cancer Medicine Market Size by Application (2018-2023)
6.3.2 World Personalized Cancer Medicine Market Size by Application (2024-2029)
6.3.3 World Personalized Cancer Medicine Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Personalized Cancer Medicine Product and Services
7.1.4 AbbVie Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Personalized Cancer Medicine Product and Services
7.2.4 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Personalized Cancer Medicine Product and Services
7.3.4 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Gilead Sciences
7.4.1 Gilead Sciences Details
7.4.2 Gilead Sciences Major Business
7.4.3 Gilead Sciences Personalized Cancer Medicine Product and Services
7.4.4 Gilead Sciences Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Gilead Sciences Recent Developments/Updates
7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
7.5 Roche
7.5.1 Roche Details
7.5.2 Roche Major Business
7.5.3 Roche Personalized Cancer Medicine Product and Services
7.5.4 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Roche Recent Developments/Updates
7.5.6 Roche Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Product and Services
7.6.4 Bristol-Myers Squibb Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Amgen
7.7.1 Amgen Details
7.7.2 Amgen Major Business
7.7.3 Amgen Personalized Cancer Medicine Product and Services
7.7.4 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Amgen Recent Developments/Updates
7.7.6 Amgen Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Personalized Cancer Medicine Product and Services
7.8.4 AstraZeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Merck & Co
7.9.1 Merck & Co Details
7.9.2 Merck & Co Major Business
7.9.3 Merck & Co Personalized Cancer Medicine Product and Services
7.9.4 Merck & Co Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co Recent Developments/Updates
7.9.6 Merck & Co Competitive Strengths & Weaknesses
7.10 Takeda
7.10.1 Takeda Details
7.10.2 Takeda Major Business
7.10.3 Takeda Personalized Cancer Medicine Product and Services
7.10.4 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Recent Developments/Updates
7.10.6 Takeda Competitive Strengths & Weaknesses
7.11 Merck KGaA
7.11.1 Merck KGaA Details
7.11.2 Merck KGaA Major Business
7.11.3 Merck KGaA Personalized Cancer Medicine Product and Services
7.11.4 Merck KGaA Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Merck KGaA Recent Developments/Updates
7.11.6 Merck KGaA Competitive Strengths & Weaknesses
7.12 Seagen
7.12.1 Seagen Details
7.12.2 Seagen Major Business
7.12.3 Seagen Personalized Cancer Medicine Product and Services
7.12.4 Seagen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Seagen Recent Developments/Updates
7.12.6 Seagen Competitive Strengths & Weaknesses
7.13 Eli Lilly
7.13.1 Eli Lilly Details
7.13.2 Eli Lilly Major Business
7.13.3 Eli Lilly Personalized Cancer Medicine Product and Services
7.13.4 Eli Lilly Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Eli Lilly Recent Developments/Updates
7.13.6 Eli Lilly Competitive Strengths & Weaknesses
7.14 Ono Pharmaceutical
7.14.1 Ono Pharmaceutical Details
7.14.2 Ono Pharmaceutical Major Business
7.14.3 Ono Pharmaceutical Personalized Cancer Medicine Product and Services
7.14.4 Ono Pharmaceutical Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Ono Pharmaceutical Recent Developments/Updates
7.14.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.15 Pfizer
7.15.1 Pfizer Details
7.15.2 Pfizer Major Business
7.15.3 Pfizer Personalized Cancer Medicine Product and Services
7.15.4 Pfizer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Pfizer Recent Developments/Updates
7.15.6 Pfizer Competitive Strengths & Weaknesses
7.16 GSK
7.16.1 GSK Details
7.16.2 GSK Major Business
7.16.3 GSK Personalized Cancer Medicine Product and Services
7.16.4 GSK Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 GSK Recent Developments/Updates
7.16.6 GSK Competitive Strengths & Weaknesses
7.17 Exelixis
7.17.1 Exelixis Details
7.17.2 Exelixis Major Business
7.17.3 Exelixis Personalized Cancer Medicine Product and Services
7.17.4 Exelixis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Exelixis Recent Developments/Updates
7.17.6 Exelixis Competitive Strengths & Weaknesses
7.18 Regeneron
7.18.1 Regeneron Details
7.18.2 Regeneron Major Business
7.18.3 Regeneron Personalized Cancer Medicine Product and Services
7.18.4 Regeneron Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Regeneron Recent Developments/Updates
7.18.6 Regeneron Competitive Strengths & Weaknesses
7.19 Innovent
7.19.1 Innovent Details
7.19.2 Innovent Major Business
7.19.3 Innovent Personalized Cancer Medicine Product and Services
7.19.4 Innovent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Innovent Recent Developments/Updates
7.19.6 Innovent Competitive Strengths & Weaknesses
7.20 Hengrui Medicine
7.20.1 Hengrui Medicine Details
7.20.2 Hengrui Medicine Major Business
7.20.3 Hengrui Medicine Personalized Cancer Medicine Product and Services
7.20.4 Hengrui Medicine Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Hengrui Medicine Recent Developments/Updates
7.20.6 Hengrui Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Personalized Cancer Medicine Industry Chain
8.2 Personalized Cancer Medicine Upstream Analysis
8.3 Personalized Cancer Medicine Midstream Analysis
8.4 Personalized Cancer Medicine Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Personalized Cancer Medicine Introduction
1.2 World Personalized Cancer Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Personalized Cancer Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Personalized Cancer Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Personalized Cancer Medicine Market Size (2018-2029)
1.3.3 China Personalized Cancer Medicine Market Size (2018-2029)
1.3.4 Europe Personalized Cancer Medicine Market Size (2018-2029)
1.3.5 Japan Personalized Cancer Medicine Market Size (2018-2029)
1.3.6 South Korea Personalized Cancer Medicine Market Size (2018-2029)
1.3.7 ASEAN Personalized Cancer Medicine Market Size (2018-2029)
1.3.8 India Personalized Cancer Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Personalized Cancer Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Personalized Cancer Medicine Major Market Trends
2 DEMAND SUMMARY
2.1 World Personalized Cancer Medicine Consumption Value (2018-2029)
2.2 World Personalized Cancer Medicine Consumption Value by Region
2.2.1 World Personalized Cancer Medicine Consumption Value by Region (2018-2023)
2.2.2 World Personalized Cancer Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Personalized Cancer Medicine Consumption Value (2018-2029)
2.4 China Personalized Cancer Medicine Consumption Value (2018-2029)
2.5 Europe Personalized Cancer Medicine Consumption Value (2018-2029)
2.6 Japan Personalized Cancer Medicine Consumption Value (2018-2029)
2.7 South Korea Personalized Cancer Medicine Consumption Value (2018-2029)
2.8 ASEAN Personalized Cancer Medicine Consumption Value (2018-2029)
2.9 India Personalized Cancer Medicine Consumption Value (2018-2029)
3 WORLD PERSONALIZED CANCER MEDICINE COMPANIES COMPETITIVE ANALYSIS
3.1 World Personalized Cancer Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Personalized Cancer Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Personalized Cancer Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Personalized Cancer Medicine in 2022
3.3 Personalized Cancer Medicine Company Evaluation Quadrant
3.4 Personalized Cancer Medicine Market: Overall Company Footprint Analysis
3.4.1 Personalized Cancer Medicine Market: Region Footprint
3.4.2 Personalized Cancer Medicine Market: Company Product Type Footprint
3.4.3 Personalized Cancer Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Personalized Cancer Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Personalized Cancer Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Personalized Cancer Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Personalized Cancer Medicine Consumption Value Comparison
4.2.1 United States VS China: Personalized Cancer Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Personalized Cancer Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Personalized Cancer Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Personalized Cancer Medicine Revenue, (2018-2023)
4.4 China Based Companies Personalized Cancer Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Personalized Cancer Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Personalized Cancer Medicine Revenue, (2018-2023)
4.5 Rest of World Based Personalized Cancer Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Personalized Cancer Medicine Revenue, (2018-2023)
5 MARKET ANALYSIS BY METHOD
5.1 World Personalized Cancer Medicine Market Size Overview by Method: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Method
5.2.1 Cancer Immunotherapy
5.2.2 Targeted Therapy
5.3 Market Segment by Method
5.3.1 World Personalized Cancer Medicine Market Size by Method (2018-2023)
5.3.2 World Personalized Cancer Medicine Market Size by Method (2024-2029)
5.3.3 World Personalized Cancer Medicine Market Size Market Share by Method (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Personalized Cancer Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Breast Cancer
6.2.3 Prostate Cancer
6.2.4 Blood-related Cancer
6.2.5 Blood-related Cancer
6.3 Market Segment by Application
6.3.1 World Personalized Cancer Medicine Market Size by Application (2018-2023)
6.3.2 World Personalized Cancer Medicine Market Size by Application (2024-2029)
6.3.3 World Personalized Cancer Medicine Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Personalized Cancer Medicine Product and Services
7.1.4 AbbVie Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Personalized Cancer Medicine Product and Services
7.2.4 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Personalized Cancer Medicine Product and Services
7.3.4 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Gilead Sciences
7.4.1 Gilead Sciences Details
7.4.2 Gilead Sciences Major Business
7.4.3 Gilead Sciences Personalized Cancer Medicine Product and Services
7.4.4 Gilead Sciences Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Gilead Sciences Recent Developments/Updates
7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
7.5 Roche
7.5.1 Roche Details
7.5.2 Roche Major Business
7.5.3 Roche Personalized Cancer Medicine Product and Services
7.5.4 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Roche Recent Developments/Updates
7.5.6 Roche Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Product and Services
7.6.4 Bristol-Myers Squibb Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Amgen
7.7.1 Amgen Details
7.7.2 Amgen Major Business
7.7.3 Amgen Personalized Cancer Medicine Product and Services
7.7.4 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Amgen Recent Developments/Updates
7.7.6 Amgen Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Personalized Cancer Medicine Product and Services
7.8.4 AstraZeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Merck & Co
7.9.1 Merck & Co Details
7.9.2 Merck & Co Major Business
7.9.3 Merck & Co Personalized Cancer Medicine Product and Services
7.9.4 Merck & Co Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co Recent Developments/Updates
7.9.6 Merck & Co Competitive Strengths & Weaknesses
7.10 Takeda
7.10.1 Takeda Details
7.10.2 Takeda Major Business
7.10.3 Takeda Personalized Cancer Medicine Product and Services
7.10.4 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Recent Developments/Updates
7.10.6 Takeda Competitive Strengths & Weaknesses
7.11 Merck KGaA
7.11.1 Merck KGaA Details
7.11.2 Merck KGaA Major Business
7.11.3 Merck KGaA Personalized Cancer Medicine Product and Services
7.11.4 Merck KGaA Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Merck KGaA Recent Developments/Updates
7.11.6 Merck KGaA Competitive Strengths & Weaknesses
7.12 Seagen
7.12.1 Seagen Details
7.12.2 Seagen Major Business
7.12.3 Seagen Personalized Cancer Medicine Product and Services
7.12.4 Seagen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Seagen Recent Developments/Updates
7.12.6 Seagen Competitive Strengths & Weaknesses
7.13 Eli Lilly
7.13.1 Eli Lilly Details
7.13.2 Eli Lilly Major Business
7.13.3 Eli Lilly Personalized Cancer Medicine Product and Services
7.13.4 Eli Lilly Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Eli Lilly Recent Developments/Updates
7.13.6 Eli Lilly Competitive Strengths & Weaknesses
7.14 Ono Pharmaceutical
7.14.1 Ono Pharmaceutical Details
7.14.2 Ono Pharmaceutical Major Business
7.14.3 Ono Pharmaceutical Personalized Cancer Medicine Product and Services
7.14.4 Ono Pharmaceutical Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Ono Pharmaceutical Recent Developments/Updates
7.14.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.15 Pfizer
7.15.1 Pfizer Details
7.15.2 Pfizer Major Business
7.15.3 Pfizer Personalized Cancer Medicine Product and Services
7.15.4 Pfizer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Pfizer Recent Developments/Updates
7.15.6 Pfizer Competitive Strengths & Weaknesses
7.16 GSK
7.16.1 GSK Details
7.16.2 GSK Major Business
7.16.3 GSK Personalized Cancer Medicine Product and Services
7.16.4 GSK Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 GSK Recent Developments/Updates
7.16.6 GSK Competitive Strengths & Weaknesses
7.17 Exelixis
7.17.1 Exelixis Details
7.17.2 Exelixis Major Business
7.17.3 Exelixis Personalized Cancer Medicine Product and Services
7.17.4 Exelixis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Exelixis Recent Developments/Updates
7.17.6 Exelixis Competitive Strengths & Weaknesses
7.18 Regeneron
7.18.1 Regeneron Details
7.18.2 Regeneron Major Business
7.18.3 Regeneron Personalized Cancer Medicine Product and Services
7.18.4 Regeneron Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Regeneron Recent Developments/Updates
7.18.6 Regeneron Competitive Strengths & Weaknesses
7.19 Innovent
7.19.1 Innovent Details
7.19.2 Innovent Major Business
7.19.3 Innovent Personalized Cancer Medicine Product and Services
7.19.4 Innovent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Innovent Recent Developments/Updates
7.19.6 Innovent Competitive Strengths & Weaknesses
7.20 Hengrui Medicine
7.20.1 Hengrui Medicine Details
7.20.2 Hengrui Medicine Major Business
7.20.3 Hengrui Medicine Personalized Cancer Medicine Product and Services
7.20.4 Hengrui Medicine Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Hengrui Medicine Recent Developments/Updates
7.20.6 Hengrui Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Personalized Cancer Medicine Industry Chain
8.2 Personalized Cancer Medicine Upstream Analysis
8.3 Personalized Cancer Medicine Midstream Analysis
8.4 Personalized Cancer Medicine Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Personalized Cancer Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Personalized Cancer Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Personalized Cancer Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Personalized Cancer Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Personalized Cancer Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Personalized Cancer Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Personalized Cancer Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Personalized Cancer Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Personalized Cancer Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Personalized Cancer Medicine Players in 2022
Table 12. World Personalized Cancer Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Personalized Cancer Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Personalized Cancer Medicine Player
Table 15. Personalized Cancer Medicine Market: Company Product Type Footprint
Table 16. Personalized Cancer Medicine Market: Company Product Application Footprint
Table 17. Personalized Cancer Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Personalized Cancer Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Personalized Cancer Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Personalized Cancer Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Personalized Cancer Medicine Revenue Market Share (2018-2023)
Table 23. China Based Personalized Cancer Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Personalized Cancer Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Personalized Cancer Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Personalized Cancer Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Personalized Cancer Medicine Revenue Market Share (2018-2023)
Table 29. World Personalized Cancer Medicine Market Size by Method, (USD Million), 2018 & 2022 & 2029
Table 30. World Personalized Cancer Medicine Market Size by Method (2018-2023) & (USD Million)
Table 31. World Personalized Cancer Medicine Market Size by Method (2024-2029) & (USD Million)
Table 32. World Personalized Cancer Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Personalized Cancer Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Personalized Cancer Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. AbbVie Basic Information, Area Served and Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Personalized Cancer Medicine Product and Services
Table 38. AbbVie Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. AbbVie Recent Developments/Updates
Table 40. AbbVie Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Personalized Cancer Medicine Product and Services
Table 44. Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Novartis Basic Information, Area Served and Competitors
Table 48. Novartis Major Business
Table 49. Novartis Personalized Cancer Medicine Product and Services
Table 50. Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis Recent Developments/Updates
Table 52. Novartis Competitive Strengths & Weaknesses
Table 53. Gilead Sciences Basic Information, Area Served and Competitors
Table 54. Gilead Sciences Major Business
Table 55. Gilead Sciences Personalized Cancer Medicine Product and Services
Table 56. Gilead Sciences Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Gilead Sciences Recent Developments/Updates
Table 58. Gilead Sciences Competitive Strengths & Weaknesses
Table 59. Roche Basic Information, Area Served and Competitors
Table 60. Roche Major Business
Table 61. Roche Personalized Cancer Medicine Product and Services
Table 62. Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Roche Recent Developments/Updates
Table 64. Roche Competitive Strengths & Weaknesses
Table 65. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 66. Bristol-Myers Squibb Major Business
Table 67. Bristol-Myers Squibb Personalized Cancer Medicine Product and Services
Table 68. Bristol-Myers Squibb Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bristol-Myers Squibb Recent Developments/Updates
Table 70. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 71. Amgen Basic Information, Area Served and Competitors
Table 72. Amgen Major Business
Table 73. Amgen Personalized Cancer Medicine Product and Services
Table 74. Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Amgen Recent Developments/Updates
Table 76. Amgen Competitive Strengths & Weaknesses
Table 77. AstraZeneca Basic Information, Area Served and Competitors
Table 78. AstraZeneca Major Business
Table 79. AstraZeneca Personalized Cancer Medicine Product and Services
Table 80. AstraZeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AstraZeneca Recent Developments/Updates
Table 82. AstraZeneca Competitive Strengths & Weaknesses
Table 83. Merck & Co Basic Information, Area Served and Competitors
Table 84. Merck & Co Major Business
Table 85. Merck & Co Personalized Cancer Medicine Product and Services
Table 86. Merck & Co Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck & Co Recent Developments/Updates
Table 88. Merck & Co Competitive Strengths & Weaknesses
Table 89. Takeda Basic Information, Area Served and Competitors
Table 90. Takeda Major Business
Table 91. Takeda Personalized Cancer Medicine Product and Services
Table 92. Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Takeda Recent Developments/Updates
Table 94. Takeda Competitive Strengths & Weaknesses
Table 95. Merck KGaA Basic Information, Area Served and Competitors
Table 96. Merck KGaA Major Business
Table 97. Merck KGaA Personalized Cancer Medicine Product and Services
Table 98. Merck KGaA Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Merck KGaA Recent Developments/Updates
Table 100. Merck KGaA Competitive Strengths & Weaknesses
Table 101. Seagen Basic Information, Area Served and Competitors
Table 102. Seagen Major Business
Table 103. Seagen Personalized Cancer Medicine Product and Services
Table 104. Seagen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Seagen Recent Developments/Updates
Table 106. Seagen Competitive Strengths & Weaknesses
Table 107. Eli Lilly Basic Information, Area Served and Competitors
Table 108. Eli Lilly Major Business
Table 109. Eli Lilly Personalized Cancer Medicine Product and Services
Table 110. Eli Lilly Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Eli Lilly Recent Developments/Updates
Table 112. Eli Lilly Competitive Strengths & Weaknesses
Table 113. Ono Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Ono Pharmaceutical Major Business
Table 115. Ono Pharmaceutical Personalized Cancer Medicine Product and Services
Table 116. Ono Pharmaceutical Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Ono Pharmaceutical Recent Developments/Updates
Table 118. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Pfizer Basic Information, Area Served and Competitors
Table 120. Pfizer Major Business
Table 121. Pfizer Personalized Cancer Medicine Product and Services
Table 122. Pfizer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pfizer Recent Developments/Updates
Table 124. Pfizer Competitive Strengths & Weaknesses
Table 125. GSK Basic Information, Area Served and Competitors
Table 126. GSK Major Business
Table 127. GSK Personalized Cancer Medicine Product and Services
Table 128. GSK Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. GSK Recent Developments/Updates
Table 130. GSK Competitive Strengths & Weaknesses
Table 131. Exelixis Basic Information, Area Served and Competitors
Table 132. Exelixis Major Business
Table 133. Exelixis Personalized Cancer Medicine Product and Services
Table 134. Exelixis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Exelixis Recent Developments/Updates
Table 136. Exelixis Competitive Strengths & Weaknesses
Table 137. Regeneron Basic Information, Area Served and Competitors
Table 138. Regeneron Major Business
Table 139. Regeneron Personalized Cancer Medicine Product and Services
Table 140. Regeneron Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Regeneron Recent Developments/Updates
Table 142. Regeneron Competitive Strengths & Weaknesses
Table 143. Innovent Basic Information, Area Served and Competitors
Table 144. Innovent Major Business
Table 145. Innovent Personalized Cancer Medicine Product and Services
Table 146. Innovent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Innovent Recent Developments/Updates
Table 148. Hengrui Medicine Basic Information, Area Served and Competitors
Table 149. Hengrui Medicine Major Business
Table 150. Hengrui Medicine Personalized Cancer Medicine Product and Services
Table 151. Hengrui Medicine Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Personalized Cancer Medicine Upstream (Raw Materials)
Table 153. Personalized Cancer Medicine Typical Customers
List of Figure
Figure 1. Personalized Cancer Medicine Picture
Figure 2. World Personalized Cancer Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Personalized Cancer Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Personalized Cancer Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Personalized Cancer Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Personalized Cancer Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Personalized Cancer Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Personalized Cancer Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Personalized Cancer Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Personalized Cancer Medicine Markets in 2022
Figure 27. United States VS China: Personalized Cancer Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Personalized Cancer Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Personalized Cancer Medicine Market Size by Method, (USD Million), 2018 & 2022 & 2029
Figure 30. World Personalized Cancer Medicine Market Size Market Share by Method in 2022
Figure 31. Cancer Immunotherapy
Figure 32. Targeted Therapy
Figure 33. World Personalized Cancer Medicine Market Size Market Share by Method (2018-2029)
Figure 34. World Personalized Cancer Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Personalized Cancer Medicine Market Size Market Share by Application in 2022
Figure 36. Lung Cancer
Figure 37. Breast Cancer
Figure 38. Prostate Cancer
Figure 39. Blood-related Cancer
Figure 40. Other
Figure 41. Personalized Cancer Medicine Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Personalized Cancer Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Personalized Cancer Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Personalized Cancer Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Personalized Cancer Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Personalized Cancer Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Personalized Cancer Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Personalized Cancer Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Personalized Cancer Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Personalized Cancer Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Personalized Cancer Medicine Players in 2022
Table 12. World Personalized Cancer Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Personalized Cancer Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Personalized Cancer Medicine Player
Table 15. Personalized Cancer Medicine Market: Company Product Type Footprint
Table 16. Personalized Cancer Medicine Market: Company Product Application Footprint
Table 17. Personalized Cancer Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Personalized Cancer Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Personalized Cancer Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Personalized Cancer Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Personalized Cancer Medicine Revenue Market Share (2018-2023)
Table 23. China Based Personalized Cancer Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Personalized Cancer Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Personalized Cancer Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Personalized Cancer Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Personalized Cancer Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Personalized Cancer Medicine Revenue Market Share (2018-2023)
Table 29. World Personalized Cancer Medicine Market Size by Method, (USD Million), 2018 & 2022 & 2029
Table 30. World Personalized Cancer Medicine Market Size by Method (2018-2023) & (USD Million)
Table 31. World Personalized Cancer Medicine Market Size by Method (2024-2029) & (USD Million)
Table 32. World Personalized Cancer Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Personalized Cancer Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Personalized Cancer Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. AbbVie Basic Information, Area Served and Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Personalized Cancer Medicine Product and Services
Table 38. AbbVie Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. AbbVie Recent Developments/Updates
Table 40. AbbVie Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Personalized Cancer Medicine Product and Services
Table 44. Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Novartis Basic Information, Area Served and Competitors
Table 48. Novartis Major Business
Table 49. Novartis Personalized Cancer Medicine Product and Services
Table 50. Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis Recent Developments/Updates
Table 52. Novartis Competitive Strengths & Weaknesses
Table 53. Gilead Sciences Basic Information, Area Served and Competitors
Table 54. Gilead Sciences Major Business
Table 55. Gilead Sciences Personalized Cancer Medicine Product and Services
Table 56. Gilead Sciences Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Gilead Sciences Recent Developments/Updates
Table 58. Gilead Sciences Competitive Strengths & Weaknesses
Table 59. Roche Basic Information, Area Served and Competitors
Table 60. Roche Major Business
Table 61. Roche Personalized Cancer Medicine Product and Services
Table 62. Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Roche Recent Developments/Updates
Table 64. Roche Competitive Strengths & Weaknesses
Table 65. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 66. Bristol-Myers Squibb Major Business
Table 67. Bristol-Myers Squibb Personalized Cancer Medicine Product and Services
Table 68. Bristol-Myers Squibb Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bristol-Myers Squibb Recent Developments/Updates
Table 70. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 71. Amgen Basic Information, Area Served and Competitors
Table 72. Amgen Major Business
Table 73. Amgen Personalized Cancer Medicine Product and Services
Table 74. Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Amgen Recent Developments/Updates
Table 76. Amgen Competitive Strengths & Weaknesses
Table 77. AstraZeneca Basic Information, Area Served and Competitors
Table 78. AstraZeneca Major Business
Table 79. AstraZeneca Personalized Cancer Medicine Product and Services
Table 80. AstraZeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AstraZeneca Recent Developments/Updates
Table 82. AstraZeneca Competitive Strengths & Weaknesses
Table 83. Merck & Co Basic Information, Area Served and Competitors
Table 84. Merck & Co Major Business
Table 85. Merck & Co Personalized Cancer Medicine Product and Services
Table 86. Merck & Co Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck & Co Recent Developments/Updates
Table 88. Merck & Co Competitive Strengths & Weaknesses
Table 89. Takeda Basic Information, Area Served and Competitors
Table 90. Takeda Major Business
Table 91. Takeda Personalized Cancer Medicine Product and Services
Table 92. Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Takeda Recent Developments/Updates
Table 94. Takeda Competitive Strengths & Weaknesses
Table 95. Merck KGaA Basic Information, Area Served and Competitors
Table 96. Merck KGaA Major Business
Table 97. Merck KGaA Personalized Cancer Medicine Product and Services
Table 98. Merck KGaA Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Merck KGaA Recent Developments/Updates
Table 100. Merck KGaA Competitive Strengths & Weaknesses
Table 101. Seagen Basic Information, Area Served and Competitors
Table 102. Seagen Major Business
Table 103. Seagen Personalized Cancer Medicine Product and Services
Table 104. Seagen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Seagen Recent Developments/Updates
Table 106. Seagen Competitive Strengths & Weaknesses
Table 107. Eli Lilly Basic Information, Area Served and Competitors
Table 108. Eli Lilly Major Business
Table 109. Eli Lilly Personalized Cancer Medicine Product and Services
Table 110. Eli Lilly Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Eli Lilly Recent Developments/Updates
Table 112. Eli Lilly Competitive Strengths & Weaknesses
Table 113. Ono Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Ono Pharmaceutical Major Business
Table 115. Ono Pharmaceutical Personalized Cancer Medicine Product and Services
Table 116. Ono Pharmaceutical Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Ono Pharmaceutical Recent Developments/Updates
Table 118. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Pfizer Basic Information, Area Served and Competitors
Table 120. Pfizer Major Business
Table 121. Pfizer Personalized Cancer Medicine Product and Services
Table 122. Pfizer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pfizer Recent Developments/Updates
Table 124. Pfizer Competitive Strengths & Weaknesses
Table 125. GSK Basic Information, Area Served and Competitors
Table 126. GSK Major Business
Table 127. GSK Personalized Cancer Medicine Product and Services
Table 128. GSK Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. GSK Recent Developments/Updates
Table 130. GSK Competitive Strengths & Weaknesses
Table 131. Exelixis Basic Information, Area Served and Competitors
Table 132. Exelixis Major Business
Table 133. Exelixis Personalized Cancer Medicine Product and Services
Table 134. Exelixis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Exelixis Recent Developments/Updates
Table 136. Exelixis Competitive Strengths & Weaknesses
Table 137. Regeneron Basic Information, Area Served and Competitors
Table 138. Regeneron Major Business
Table 139. Regeneron Personalized Cancer Medicine Product and Services
Table 140. Regeneron Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Regeneron Recent Developments/Updates
Table 142. Regeneron Competitive Strengths & Weaknesses
Table 143. Innovent Basic Information, Area Served and Competitors
Table 144. Innovent Major Business
Table 145. Innovent Personalized Cancer Medicine Product and Services
Table 146. Innovent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Innovent Recent Developments/Updates
Table 148. Hengrui Medicine Basic Information, Area Served and Competitors
Table 149. Hengrui Medicine Major Business
Table 150. Hengrui Medicine Personalized Cancer Medicine Product and Services
Table 151. Hengrui Medicine Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Personalized Cancer Medicine Upstream (Raw Materials)
Table 153. Personalized Cancer Medicine Typical Customers
List of Figure
Figure 1. Personalized Cancer Medicine Picture
Figure 2. World Personalized Cancer Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Personalized Cancer Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Personalized Cancer Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Personalized Cancer Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Personalized Cancer Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Personalized Cancer Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Personalized Cancer Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Personalized Cancer Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Personalized Cancer Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Personalized Cancer Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Personalized Cancer Medicine Markets in 2022
Figure 27. United States VS China: Personalized Cancer Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Personalized Cancer Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Personalized Cancer Medicine Market Size by Method, (USD Million), 2018 & 2022 & 2029
Figure 30. World Personalized Cancer Medicine Market Size Market Share by Method in 2022
Figure 31. Cancer Immunotherapy
Figure 32. Targeted Therapy
Figure 33. World Personalized Cancer Medicine Market Size Market Share by Method (2018-2029)
Figure 34. World Personalized Cancer Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Personalized Cancer Medicine Market Size Market Share by Application in 2022
Figure 36. Lung Cancer
Figure 37. Breast Cancer
Figure 38. Prostate Cancer
Figure 39. Blood-related Cancer
Figure 40. Other
Figure 41. Personalized Cancer Medicine Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
